Transcatheter Interventions Online | Day 3 – Recent trials & future technologies

Transcatheter Interventions Online | Day 3 – Recent trials & future technologies
12th June | 4-8pm CEST (10am – 2pm ET)

Reserve Your Seat for this event.

NEW USER

EXISTING ACCOUNT USERS

Transcatheter Interventions Online

Day 3 – Recent trials & future technologies

12th June | 4-8pm CEST (10am – 2pm ET)

Prof Nicolas M Van Mieghem (Erasmus MC, Rotterdam, NL)

The programme aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centres of excellence globally, interspersed with presentations and debate sessions.

CME Accreditation

This three-day programme has been accredited by the European Board for Accreditation in Cardiology (EBAC) for a total of 12 CME points, equating to 12 hours of learning (4 hours per day). Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website https://www.ama-assn.org/

Day 1 - Structural Heart Interventions

10th June 4-8pm CEST (10am – 2pm ET)

Register

Day 2: Complex & High Risk Indicated PCI

11th June 4-8pm CEST (10am – 2pm ET)

Register

Day 3: Updates on recent trials & future technologies

12th June 4-8pm CEST (10am – 2pm ET)

Register

Day 3: 4pm-8pm CEST, 12 June - Recent Trials & Future Technologies

Subject to change

4 - 5.30pm: PART 3.1 - Trials - 90 minutes
Intro: Nicolas Van Mieghem
SESSION CHAIRS: Roxana Mehran, Holger Thiele
SESSION PANEL: Ajay Kirtane, Lars Sondergaard, Kendra Grubb, David Hildick-Smith


1. ISCHEMIA practical perspectives – 15 minutes – Ajay Kirtane
10 minutes discussion

2. Latest in pharmacology: acute and stable coronary syndromes – 15 minutes – Roxana Mehran
10 minutes discussion

3. Recent TAVI data – 15 minutes – Lars Sondergaard
10 minutes discussion


5.30 - 6.30pm: PART 3.2 - Live Cases - 60 minutes

1. Erasmus Medical Center, NL (MV/LM PCI)

2. Erasmus Medical Center, NL (MV/LM PCI)


6 - 7.50pm: PART 3.3 - Future Technologies and Controversies - 80 minutes
SESSION CHAIRS: Nicolas Van Mieghem, Ajay Kirtane
SESSION PANEL: Holger Thiele, Didier Tchetche, David Hildick-Smith, Roxana Mehran


1. MCS in HRPCI – Changing perspectives? – 15 minutes – Holger Thiele
15 minutes discussion

2. Non-hyperemic angio-, OCT-, MSCT derived coronary physiology – 15 minutes – Joost Daemen
10 minutes discussion

3. Embolic protection in TAVI – 15 minutes – David Hildick-Smith
10 minutes discussion


7.50pm: Wrap up of Day 3 - Led by Nicolas Van Mieghem - 10 minutes

Course Director

  • Prof Nicolas Van Mieghem (Rotterdam, NL)

 

Co-Course Directors

  • Dr Kendra Grubb (Atlanta, US)
  • Prof David Hildick-Smith (Brighton, UK)
  • Prof Holger Thiele (Leipzig, DE)

 

Scientific Committee

  • Dr Roxana Mehran (New York, US)
  • Dr Didier Tchetche (Toulouse, FR)
  • Dr Ajay Kirtane (New York, US)
  • Prof Lars Sondergaard (Copenhagen, DK)
  • Dr Azeem Latib (New York, US)
  • Dr Joost Daemen (Rotterdam, NL)
  • Dr MargaretMcEntegart (Glasgow, UK)

Cardiologists, interventionalists and surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease.

Following the activities, the participants will be able to:

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.